{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:23:40Z","timestamp":1788013420344,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>A clinical diagnosis of multiple endocrine neoplasia type 1 (MEN1) syndrome is usually confirmed with genetic testing in the germline. It is expected that menin protein expression is lost in MEN1-related tumors. Therefore, we investigated the potential of menin immunohistochemistry in parathyroid adenomas as an additional tool in the recognition and genetic diagnosis of MEN1 syndrome. Local pathology archives were searched for parathyroid tumors from patients with MEN1 syndrome and without MEN1, including sporadic, patients with multiple endocrine neoplasia type 2A and hyperparathyroidism-jaw parathyroid tumors. Menin immunohistochemistry was performed and its use to identify MEN1-related tumors was assessed. Twenty-nine parathyroid tumors from 16 patients with MEN1 and 61 patients with parathyroid tumors from 32 non-MEN1 were evaluated. Immunohistochemical nuclear menin loss in one or more tumors was found in 100% of patients with MEN1 and 9% of patients with non-MEN1. In patients with multiple tumors, menin loss in at least one tumor was seen in 100% of 8 patients with MEN1 and 21% of patients with 14 non-MEN1. Using a cutoff of at least 2 tumors showing menin loss per patient, the positive and negative predictive values for the diagnosis MEN1 were both 100%. The practical and additional value of menin immunohistochemistry in clinical genetic MEN1 diagnosis is further illustrated by menin immunohistochemistry in 2 cases with a germline variant of unknown significance in the <jats:italic toggle=\"yes\">MEN1<\/jats:italic> gene. Menin immunohistochemistry is useful in the recognition of <jats:italic toggle=\"yes\">MEN1<\/jats:italic> syndrome as well as in the clinical genetic analysis of patients with inconclusive <jats:italic toggle=\"yes\">MEN1<\/jats:italic> germline testing.<\/jats:p>","DOI":"10.1097\/pas.0000000000002050","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:03:12Z","timestamp":1684414992000},"page":"785-791","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome"],"prefix":"10.1097","volume":"47","author":[{"given":"Anna Vera D.","family":"Verschuur","sequence":"first","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aranxa S.M.","family":"Kok","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert H.M.","family":"Morsink","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W.J.","family":"de Leng","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medard F.M","family":"van den Broek","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco J.","family":"Koudijs","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan A.","family":"Offerhaus","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D.","family":"Valk","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R.","family":"Vriens","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgical Oncology, University Medical Center Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette P.M.","family":"van Nesselrooij","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel M.","family":"Hackeng","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk A.A.","family":"Brosens","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2006.09.004","article-title":"Menin and its interacting proteins: elucidation of menin function","volume":"17","author":"Balogh","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.GIM.0000153663.62300.F8","article-title":"Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory","volume":"7","author":"Klein","year":"2005","journal-title":"Genet Med"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fendo.2018.00533","article-title":"The importance of an early and accurate MEN1 diagnosis","volume":"9","author":"de Laat","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","article-title":"Update on multiple endocrine neoplasia type 1 and 2","volume":"47","author":"Al-Salameh","year":"2018","journal-title":"Presse Med"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-12-0210","article-title":"Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors","volume":"167","author":"de Laat","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2015-3766","article-title":"Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 Study Group","volume":"101","author":"van Leeuwaarde","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40618-017-0783-y","article-title":"Expression of p27(Kip1) and p18(Ink4c) in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors","volume":"41","author":"Conemans","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2016.06.006","article-title":"Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis","volume":"56","author":"Hackeng","year":"2016","journal-title":"Hum Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-12-0327","article-title":"MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism","volume":"168","author":"Alvelos","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jcem.85.7.6688","article-title":"Expression of menin in parathyroid tumors","volume":"85","author":"Bhuiyan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-017-2158-3","article-title":"MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism","volume":"471","author":"Grolmusz","year":"2017","journal-title":"Virchows Arch"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:01:04Z","timestamp":1749416464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002050","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}